Compare CNK & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNK | PRGO |
|---|---|---|
| Founded | 1984 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 2.0B |
| IPO Year | 2007 | 2013 |
| Metric | CNK | PRGO |
|---|---|---|
| Price | $34.92 | $13.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $33.70 | $19.33 |
| AVG Volume (30 Days) | 1.7M | ★ 2.3M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | 1.24% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,115,000,000.00 | $800,000.00 |
| Revenue This Year | $11.01 | N/A |
| Revenue Next Year | $3.70 | $1.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $21.60 | $9.23 |
| 52 Week High | $38.98 | $22.65 |
| Indicator | CNK | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 46.94 |
| Support Level | $25.40 | $12.74 |
| Resistance Level | $36.20 | $13.66 |
| Average True Range (ATR) | 0.97 | 0.56 |
| MACD | -0.20 | -0.23 |
| Stochastic Oscillator | 40.52 | 10.03 |
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.